XML 160 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders Equity  
Schedule of restricted stock shares activity

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value per Share

 

Outstanding at December 31, 2023

 

 

264,650

 

 

 

5.01

 

Nonvested as of December 31, 2023

 

 

264,650

 

 

 

5.01

 

Outstanding at March 31, 2024

 

 

264,650

 

 

 

5.01

 

Nonvested as of March 31, 2024

 

 

264,650

 

 

 

5.01

 

Schedule of stock option activity

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual (years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2023

 

 

6,295,858

 

 

 

4.96

 

 

 

4.5

 

 

 

-

 

Nonvested as of December 31, 2023

 

 

5,946,320

 

 

 

5.01

 

 

 

4.7

 

 

 

-

 

Exercisable as of December 31, 2023

 

 

349,538

 

 

 

4.15

 

 

 

2.5

 

 

 

300,000

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exchanged

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled or forfeited

 

 

(48,183 )

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding at March 31, 2024

 

 

6,247,675

 

 

 

4.93

 

 

 

4.3

 

 

 

-

 

Nonvested as of March 31, 2024

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable as of March 31, 2024

 

 

6,247,675

 

 

 

4.93

 

 

 

4.3

 

 

 

-

 

Schedule of nonvested option awards activity

Balance at December 31, 2023

 

$5,946,320

 

Granted

 

 

-

 

Forfeited

 

 

 (48,183

)

Vested

 

 

(5,898,137 )

Balance at March 31, 2024

 

$-